Screening for Colorectal Neoplasias with Fecal Occult Blood Tests: False-positive Impact of Non-Dietary Restriction

被引:9
|
作者
Roslani, April Camilla [1 ]
Abdullah, Taufiq [2 ]
Arumugam, Kulenthran [1 ]
机构
[1] Univ Malaya, Canc Res Inst, Kuala Lumpur, Malaysia
[2] Univ Malaya, Med Educ & Res Dev Unit, Kuala Lumpur, Malaysia
关键词
Colorectal cancer; fecal occult blood test; screening; diet restriction; CANCER STATISTICS; CONTROLLED TRIAL; COLONOSCOPY; POPULATION; SURVIVAL;
D O I
10.7314/APJCP.2012.13.1.237
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Screening for colorectal cancer using guaiac-based fecal occult blood tests (gFOBT) is well established in Western populations, but is hampered by poor patient compliance due to the imposed dietary restrictions. Fecal immunochemical tests (FIT) do not require dietary restriction, but are more expensive than gFOBT and therefore restrict its use in developing countries in Asia. However, Asian diets being low in meat content may not require diet restriction for gFOBT to achieve equivalent results. The objective of this study was to evaluate and compare the validity and suitability of gFOBT and FIT or a combination of the two in screening for colorectal neoplasias without prior dietary restriction in an Asian population. Methods: Patients referred to the Endoscopic Unit for colonoscopy were recruited for the study. Stool samples were collected prior to bowel preparation, and tested for occult blood with both gFOBT and FIT. Dietary restriction was not imposed. To assess the validity of either tests or in combination to detect a neoplasm or cancer in the colon, their false positive rates, their sensitivity (true positive rate) and the specificity (true negative rate) were analyzed and compared. Results: One hundred and three patients were analysed. The sensitivity for picking up any neoplasia was 53% for FIT, 40% for gFOBT and 23.3% for the combination. The sensitivities for picking up only carcinoma were 77.8%, 66.7% and 55.5%, respectively. The specificity for excluding any neoplasia was 91.7% for FIT, 74% for gFOBT and 94.5% for a combination, whereas for excluding only carcinomas they were 84%, 73.4% and 93.6%. Of the 69 with normal colonoscopic findings, FOBT was positive in 4.3%, 23.2 % and 2.9% for FIT, gFOBT, or combination of tests respectively. Conclusion: FIT is the recommended method if we are to dispense with dietary restriction in our patients because of its relatively low-false positivity and better sensitivity and specificity rates.
引用
收藏
页码:237 / 241
页数:5
相关论文
共 50 条
  • [21] False-positive fecal immunochemical test results in colorectal cancer screening and gastrointestinal drug use
    Domper Arnal, M. J.
    Garcia Mateo, S.
    Hermoso-Duran, S.
    Abad, D.
    Carrera-Lasfuentes, P.
    Velazquez-Campoy, A.
    Abian Franco, O.
    Lanas, A.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2021, 36 (09) : 1861 - 1869
  • [22] False-positive fecal immunochemical test results in colorectal cancer screening and gastrointestinal drug use
    M. J. Domper Arnal
    S. García Mateo
    S. Hermoso-Durán
    D. Abad
    P. Carrera-Lasfuentes
    A. Velazquez-Campoy
    O. Abian Franco
    A. Lanas
    International Journal of Colorectal Disease, 2021, 36 : 1861 - 1869
  • [23] Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening
    Rabeneck, Linda
    Rumble, R. Bryan
    Thompson, Frank
    Mills, Michael
    Oleschuk, Curtis
    Whibley, Alexandra
    Messersmith, Hans
    Lewis, Nancy
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 26 (03) : 131 - 147
  • [24] Is It Necessary to Repeat Fecal Occult Blood Tests with Borderline Results for Colorectal Cancer Screening?
    Lee, Eunyoung
    Lee, Yangsoon
    ANNALS OF LABORATORY MEDICINE, 2018, 38 (01) : 51 - 53
  • [25] Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics
    Allison, James E.
    Sakoda, Lori C.
    Levin, Theodore R.
    Tucker, Jo P.
    Tekawa, Irene S.
    Cuff, Thomas
    Pauly, Mary Pat
    Shlager, Lyle
    Palitz, Albert M.
    Zhao, Wei K.
    Schwartz, J. Sanford
    Ransohoff, David F.
    Selby, Joseph V.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (19): : 1462 - 1470
  • [26] The impact of antithrombotics on immunochemical fecal occult blood testing for colorectal cancer screening
    Van der Voort, V.
    Wauters, L.
    Dobbels, P.
    Hendrickx, K.
    Casneuf, V.
    Vandervoort, J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [27] SENSITIVITY OF DIAGNOSTIC TECHNIQUES IN PATIENTS WITH POSITIVE FECAL OCCULT BLOOD SCREENING-TESTS
    WINAWER, S
    WESTON, E
    HAJDU, S
    EDELMAN, M
    SHERLOCK, P
    STEARNS, M
    MILLER, D
    GASTROINTESTINAL ENDOSCOPY, 1978, 24 (04) : 213 - 213
  • [28] Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancer
    Cole, SR
    Young, GP
    MEDICAL JOURNAL OF AUSTRALIA, 2001, 175 (04) : 195 - 198
  • [29] Correction to: False-positive fecal immunochemical test results in colorectal cancer screening and gastrointestinal drug use
    M. J. Domper Arnal
    S. García Mateo
    S. Hermoso-Durán
    D. Abad
    P. Carrera-Lasfuentes
    A. Velazquez-Campoy
    O. Abian Franco
    A. Lanas
    International Journal of Colorectal Disease, 2021, 36 : 1871 - 1871
  • [30] Colorectal Cancer Screening With Traditional and New-generation Fecal Immunochemical Tests: A Critical Review of Fecal Occult Blood Tests
    Meklin, Jannica
    Syrjanen, Kari
    Eskelinen, Matti
    ANTICANCER RESEARCH, 2020, 40 (02) : 575 - 581